Compare Citius Pharmaceuticals Inc (CTXR) vs SAP SE (SAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs SAP SE — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while SAP SE trades at $206.23 (market cap $240.81B). The key difference: SAP SE is far larger — about 12034.5× Citius Pharmaceuticals Inc's market cap, and SAP SE pays a 1.4% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | SAP | |
|---|---|---|
Market Cap | $20.01M | $240.81B |
Sector | Health | Technology |
52-Week High | $1.82 | $280.46 |
52-Week Low | $0.48 | $146.38 |
Enterprise Value | $16.23M | $239.52B |
Dividend Yield | — | 1.4% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About SAP SE
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.
Read more on SAP →
